Arsenic turns stem cells cancerous, spurring tumor growth

Researchers at the National Institutes of Health have discovered how exposure to arsenic can turn normal stem cells into cancer stem cells and spur tumor growth. Inorganic arsenic, which affects the drinking water of millions of people worldwide, has been previously shown to be a human carcinogen. A growing body of evidence suggests that cancer … Read more

Bladder tests before urinary incontinence surgery in women may be unnecessary

The National Institutes of Health today unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients. NIH’s new National Center for Advancing Translational Sciences (NCATS) has partnered initially with Pfizer, AstraZeneca, and Eli Lilly and Company which have agreed to make dozens … Read more

Launches collaborative program with industry and researchers to spur therapeutic development

The National Institutes of Health today unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients. NIH’s new National Center for Advancing Translational Sciences (NCATS) has partnered initially with Pfizer, AstraZeneca, and Eli Lilly and Company which have agreed to make dozens … Read more

Dr. Gary H. Gibbons director of the National Heart, Lung, and Blood Institute

National Institutes of Health Director Francis S. Collins M.D., Ph.D., announced today the selection of Gary H. Gibbons, M.D., as the new director of the NIH’s National Heart, Lung, and Blood Institute (NHLBI). Dr. Gibbons is the founder and current director of the Cardiovascular Research Institute, chairperson of the Department of Physiology, and professor of … Read more

Dr. Edward P. Riley to deliver 4th annual Jack Mendelson Honorary Lecture

The National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, announces that Edward P. Riley, Ph.D. will deliver the 4th annual Jack Mendelson Honorary Lecture. Riley is a world-renowned expert on Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Spectrum Disorders (FASD). His presentation is called “FASD: It’s What’s Behind … Read more

New classification criteria released for research on Sjogren’s Syndrome

An international team of researchers released new classification criteria for the common autoimmune condition Sjogren’s syndrome. Classification criteria are the consensus opinion of a group of experts that researchers use in clinical studies to confirm a previous diagnosis and/or subclassify patients who have the same type of a given condition.

Test links strains of common parasite to severe illness in U.S. newborns

Scientists have identified which strains of the Toxoplasma gondii parasite, the cause of toxoplasmosis, are most strongly associated with premature births and severe birth defects in the United States. The researchers used a new blood test developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of … Read more

Avastin and Lucentis are equivalent in treating age-related macular degeneration

At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although greater improvements in vision were seen with monthly administration for this common, debilitating eye disease, according to researchers supported by the National Institutes of … Read more

Anti-HIV drug use during pregnancy does not affect infant size, birth weight

nfants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens that do not include tenofovir during pregnancy, according to findings from a National Institutes … Read more